[1-(4-氨基甲基-苯基)-吡咯烷基-3-基]-氨基甲酸叔丁酯-丁酯 | 885957-73-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: [1-(4-氨基甲基-苯基)-吡咯烷基-3-基]-氨基甲酸叔丁酯-丁酯
• 英文名称: 2,4-Dimethyl-benzamidine
• 英文别名: 2,4-dimethylbenzenecarboximidamide
• CAS: 885957-73-3
• 化学式: C₉H₁₂N₂
• 分子量: 148.2
• InChiKey: ZBRUZISBYVTPAC-UHFFFAOYSA-N

物化性质

• 沸点：
  246.7±50.0 °C(Predicted)
• 密度：
  1.05±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  49.9
• 氢给体数：
  2
• 氢受体数：
  1

文献信息

• [EN] COMPOSITIONS AND METHODS THEREOF<br/>[FR] COMPOSITIONS ET PROCÉDÉS ASSOCIÉS
  申请人：EXCIVA UG HAFTUNGSBESCHRAENKT

  公开号：WO2018039642A1

  公开（公告）日：2018-03-01

  Compounds of formula I, (I) or enantiomers thereof, metabolites thereof, derivatives thereof, deuterated derivatives thereof, halogenated derivatives thereof, prodrugs thereof, pharmaceutically acceptable salts thereof, N- oxides thereof, or a combination thereof, processes and intermediates for preparation thereof, compositions thereof, and uses thereof, are provided. Pharmaceutical compositions comprising a compound of formula I and a compound of Formula II: (IIa) (IIb) or enantiomers thereof, metabolites thereof, derivatives thereof, deuterated derivatives thereof, prodrugs thereof, pharmaceutically acceptable salts thereof, N-oxides thereof, or a combination thereof. Compositions and methods for improving the efficacy of DEX, or providing beneficial pharmacokinetic effects to DEX, comprising co-administering a compound of formula I or SARPO, and a compound of Formula II or DEX to a subject in need thereof, and dosage forms, drug delivery systems, methods of treatment thereof.

  提供具有公式I的化合物(I)或其对应异构体、代谢物、衍生物、氘化衍生物、卤化衍生物、前药、药用可接受盐、N-氧化物或其组合，以及它们的制备过程和中间体、组合物和使用方法。包含公式I化合物的药物组合物以及公式II的化合物(IIa) (IIb)或其对应异构体、代谢物、衍生物、氘化衍生物、前药、药用可接受盐、N-氧化物或其组合。包含共给予需要该物质的受试者公式I化合物或SARPO和公式II化合物或DEX的DEX效能改进或提供DEX有益药代动力学效果的组合物和方法，以及剂量形式、药物传递系统、治疗方法。
• Insecticidal and acaricidal agent
  申请人：AGRO-KANESHO CO., LTD.

  公开号：US20030191171A1

  公开（公告）日：2003-10-09

  The present invention provides an insecticidal or acaricidal composition having an excellent pesticidal effect and a high safety, containing, as an active ingredient, a pyrazolyl compound of the following general formula (I): 1 wherein A represents a hydrogen atom; an alkyl group which may be substituted; an alkenyl group which may be substituted; an alkynyl group which may be substituted; a tri-substituted silyl group substituted with an alkyl group and/or an aryl group: an aryl group which may be substituted; or a heterocyclic group which may be substituted; B represents a single bond; a group of the formula: -(G 1 ) n -G 2 -(G 1 ) m - wherein G 1 represents an oxygen atom, a sulfur atom, a sulfinyl group or a sulfonyl group, G 2 represents an alkylene group, an alkenylene group or an alkynylene group, and n and m are independent from each other and represent 0 or 1; carbonyl group; a group of the formula: —CH 2 —O—N═C(R 3 )— wherein R 3 represents a hydrogen atom, an alkyl group or a haloalkyl group; or a group of the formula: —CH═N—O—(CR 3 R 4 ) n — wherein R 3 and R 4 each represents a hydrogen atom, an alkyl group or a haloalkyl group; and n is 0 or 1, R 1 represents a hydrogen atom; a halogen atom, an alkyl group which may be substituted; an alkenyl group which may be substituted; an alkynyl group which may be substituted; an alkoxyl group which may be substituted; or an aryl group which may be substituted, R 2 represents a hydrogen atom; an alkyl group; a haloalkyl group; or an aryl group which may be substituted, and D represents a group of the formula: —C(═Y)COX wherein X represents a hydroxyl group, an alkoxyl group or an alkylamino group, Y represents a group of the formula: CH-(G 3 ) n -G 4 - wherein G 3 represents an oxygen atom or a sulfur atom, G4 represents an alkyl group or a haloalkyl group, and n represents 0 or 1, a group of the formula: N—O-G 4 wherein G 4 represents an alkyl group or a haloalkyl group; or a group of the formula: —N(R 5 )CO 2 G 5 wherein R 5 represents an alkyl group, an alkenyl group, an alkynyl group, an alkylthioalkyl group or an alkoxyalkyl group, and G 5 represents an alkyl group.

  本发明提供了一种具有优异的杀虫或杀螨效果和高安全性的杀虫剂或杀螨剂组合物，其包含以下通式（I）的吡唑基化合物作为活性成分：其中，A表示氢原子；可以被取代的烷基基团；可以被取代的烯基基团；可以被取代的炔基基团；被取代的三取代硅基团，其被取代的基团为烷基和/或芳基；可以被取代的芳基基团；或可以被取代的杂环基团；B表示单键；一个式子的基团：-(G1)n-G2-(G1)m-，其中，G1表示氧原子、硫原子、亚砜基或磺酰基，G2表示烷基、烯基或炔基，n和m是独立的，表示0或1；羰基基团；一个式子的基团：—CH2—O—N═C(R3)—，其中，R3表示氢原子、烷基或卤代烷基；或一个式子的基团：—CH═N—O—(CR3R4)n—，其中，R3和R4分别表示氢原子、烷基或卤代烷基；n为0或1；R1表示氢原子；卤原子、可以被取代的烷基基团；可以被取代的烯基基团；可以被取代的炔基基团；可以被取代的烷氧基；或可以被取代的芳基基团；R2表示氢原子；烷基；卤代烷基；或可以被取代的芳基基团；D表示一个式子的基团：—C(═Y)COX，其中，X表示羟基、烷氧基或烷基氨基基团，Y表示一个式子的基团：CH-(G3)n-G4-，其中，G3表示氧原子或硫原子，G4表示烷基或卤代烷基，n表示0或1；一个式子的基团：N—O-G4，其中，G4表示烷基或卤代烷基；或一个式子的基团：—N(R5)CO2G5，其中，R5表示烷基、烯基、炔基、烷硫基烷基或烷氧基烷基，G5表示烷基。
• Diagnostic/therapeutic agents
  申请人：Klaveness Jo

  公开号：US20050002865A1

  公开（公告）日：2005-01-06

  Targetable diagnostic and/or therapeutically active agents, e.g. ultrasound contrast agents, comprising a suspension in an aqueous carrier liquid of a reporter comprising gas-containing or gas-generating material, said agent being capable of forming at least two types of binding pairs with a target.

  可定位的诊断和/或治疗活性剂，例如超声对比剂，包括悬浮在水载体液中的报告物，该报告物包含含气体或生成气体的材料，该剂能够与目标形成至少两种结合对。
• 9-(N-methyl-piperidyliden-4)-thioxanthene for treatment of pulmonary hypertension and migraine
  申请人：Biofrontera Pharmaceuticals GmbH

  公开号：EP1655027A1

  公开（公告）日：2006-05-10

  The present invention relates to use of pimethixene as a medicament for the treatment of diseases aggravated by increased levels of 5-HT and mediated by 5-HT2B receptors, such as for example pulmonary hypertension, migraine, disorders of the gastrointestinal tract, restenosis, prostatic hyperplasia and priapism.

  本发明涉及将苄噻吩用作一种药物，用于治疗因 5-HT 水平升高而加重并由 5-HT2B 受体介导的疾病，例如肺动脉高压、偏头痛、胃肠道疾病、血管再狭窄、前列腺增生和膀胱炎。
• Methods and compositions for treating cancer using P2RX2 inhibitors
  申请人：Flagship Pioneering Innovations V, Inc.

  公开号：US10457740B1

  公开（公告）日：2019-10-29

  The present invention provides methods for treating cancer using P2RX2 inhibitors, such as P2RX2 inhibitory antibodies, among others. The invention also features compositions containing P2RX2 inhibitors, methods of diagnosing patients with P2RX2-associated cancer, and methods of predicting the response of cancer in a subject to treatment with P2RX2 inhibitors.

  本发明提供了使用 P2RX2 抑制剂（如 P2RX2 抑制抗体等）治疗癌症的方法。本发明还包括含有 P2RX2 抑制剂的组合物、诊断 P2RX2 相关癌症患者的方法以及预测癌症对 P2RX2 抑制剂治疗的反应的方法。